Uploaded June 2026 | Updated September 2026, 3 days ago
How should continuous glucose monitoring (CGM) be used in people living with type 2 diabetes?
In this episode, Vivienne Parry sits down with Dame Melanie and Prof. Amanda Adler to discuss the development of a new EASD clinical guideline designed to provide evidence-based recommendations on the use of CGM in type 2 diabetes.
The conversation explores why CGM was identified as a priority topic, how clinical guidelines are developed, the role of patient representatives, and the importance of evaluating outcomes that matter most to people living with diabetes—not just glucose measurements.
They also discuss how guideline recommendations can influence clinical practice, healthcare policy, and future access to diabetes technologies across Europe and beyond.
Subscribe for more expert interviews, scientific highlights, and clinical updates from EASD Annual Meeting.
How should continuous glucose monitoring (CGM) be used in people living with type 2 diabetes?
In this episode, Vivienne Parry sits down with Dame Melanie and Prof. Amanda Adler to discuss the development of a new EASD clinical guideline designed to provide evidence-based recommendations on the use of CGM in type 2 diabetes.
The conversation explores why CGM was identified as a priority topic, how clinical guidelines are developed, the role of patient representatives, and the importance of evaluating outcomes that matter most to people living with diabetes—not just glucose measurements.
They also discuss how guideline recommendations can influence clinical practice, healthcare policy, and future access to diabetes technologies across Europe and beyond.
Subscribe for more expert interviews, scientific highlights, and clinical updates from EASD Annual Meeting.
